About the Webinar

Take a deep dive into the science behind shockwave therapy to understand what makes this modality the clinical treatment choice for addressing pain and inflammation in orthopaedic conditions.¹ Designed to activate connective tissue from the surface level to difficult-to-reach pathologies, learn how the new Intelect® RPW 2 helps to reduce wear and strain on the clinician’s hands and arms while addressing a wide range of conditions.2,3,4,5

 

1 Schmitz C. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull. 2015;116:115-38. doi: 10.1093/bmb/ldv047. Epub 2015 Nov 18.

2 Gerdesmeyer L. Current evidence of extracorporeal shock wave therapy in chronic Achilles tendinopathy.NCBINCBI Logo Int J Surg. 2015 Dec;24(Pt B):154-9. doi: 10.1016/j.ijsu.2015.07.718. Epub 2015 Aug 29.

3 Gerdesmeyer L. Current evidence of extracorporeal shock wave therapy in chronic Achilles tendinopathy.NCBINCBI Logo Int J Surg. 2015.

4 Nedelka T.Mechano-transduction effect of shockwaves in the treatment of lumbar facet joint pain.Neuro Endocrinol Lett. 2014

5 Ogden JA. Shockwave therapy for chronic proximal plantar fasciitis: a meta-analysis. Foot Ankle Int. 2002 Apr;23(4):301-8

Speaker BG Image

Speakers

Speaker Image

Cliff Eaton, MSc, MCSP

International Clinical Support Specialist at Enovis

Cliff Eaton received his MSc in Sports Injury Management from Manchester Metropolitan University and has been a part of the sports medicine staff for multiple professional sports teams, such as Northampton Saints RFC.

Speaker Image

Dr. Mark Callanen, PT, DPT, OCS

Director of Clinical Education at Enovis

Dr. Mark Callanen has been with Chattanooga since 2020, serving as the Director of Clinical Education. He has been a PT since 1999 and board certified OCS by the APTA since 2003.